FDA Clearance Tracker · DEN160003
Quantidex qPCR BCR-ABL IS Kit
Last checked: Nov 20, 2026Latest source record: Jul 22, 2016 (this decision)Source: openFDAMethods & limitations
Decided
Jul 22, 2016
De Novo granted
Time to decision
185 days
Received Jan 19, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN160003
- Device name
- Quantidex qPCR BCR-ABL IS Kit
- Applicant
- Asuragen, Inc.
- Applicant location
- Austin, TX
- Received
- Jan 19, 2016
- Decided
- Jul 22, 2016
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device type
- Bcr/Abl1 Monitoring Test (OYX)
- Device class
- Class II
- Regulation
- 21 CFR 866.6060
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN160003
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Asuragen, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- AmplideX Fragile X Dx & Carrier Screen KitNew device typeDe Novo
DEN190023 · Decided Feb 21, 2020 · 309 days after receipt
Device type: Inherited Nucleotide Repeat Disorder Dna Test (OYV) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.